| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GDC-0449 | GDSC1000 | pan-cancer | AAC | -0.084 | 0.02 |
| mRNA | JW-55 | CTRPv2 | pan-cancer | AAC | 0.17 | 0.02 |
| mRNA | CHIR-99021 | CTRPv2 | pan-cancer | AAC | 0.074 | 0.02 |
| mRNA | Nutlin-3a (-) | GDSC1000 | pan-cancer | AAC | -0.079 | 0.02 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | 0.071 | 0.02 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | 0.072 | 0.02 |
| mRNA | BRD-K27224038 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.02 |
| mRNA | BRD-K44224150 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.02 |
| mRNA | BRD-K84807411 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.02 |
| mRNA | AA-COCF3 | CTRPv2 | pan-cancer | AAC | 0.078 | 0.02 |